BNP Paribas Financial Markets’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $170K | Buy |
30,996
+25,426
| +456% | +$139K | ﹤0.01% | 3032 |
|
2025
Q1 | $35K | Sell |
5,570
-2,116
| -28% | -$13.3K | ﹤0.01% | 3564 |
|
2024
Q4 | $31.7K | Sell |
7,686
-4,244
| -36% | -$17.5K | ﹤0.01% | 3739 |
|
2024
Q3 | $39.8K | Buy |
11,930
+6,764
| +131% | +$22.6K | ﹤0.01% | 2931 |
|
2024
Q2 | $15.4K | Sell |
5,166
-15,411
| -75% | -$45.9K | ﹤0.01% | 2995 |
|
2024
Q1 | $71K | Sell |
20,577
-111,632
| -84% | -$385K | ﹤0.01% | 2848 |
|
2023
Q4 | $177K | Buy |
132,209
+122,543
| +1,268% | +$164K | ﹤0.01% | 2551 |
|
2023
Q3 | $21.1K | Sell |
9,666
-1,183
| -11% | -$2.58K | ﹤0.01% | 2880 |
|
2023
Q2 | $25.9K | Buy |
+10,849
| New | +$25.9K | ﹤0.01% | 2945 |
|